Author

A. Hunt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2 Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:cell type annotation· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cell-cell communication· 1 Assay:electronic health records· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

D. Goldblatt· 2 shared M. Johnson· 2 shared M. Treeck· 2 shared A. Apolo· 1 shared A. Berger· 1 shared A. Heaslip· 1 shared A. L. Mai· 1 shared A. Rumyantsev· 1 shared

Activity by Year

2019-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Goldblatt

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities

P. A. Desai, N. Takahashi, R. Kumar, S. Nichols, J. Malin, A. Hunt, C. Schultz, Y. Cao, D. Tillo, D. Nousome, L. Chauhan, L. Sciuto, K. Jordan, V. Rajapakse, D. Lissa, , R. El Meskini

This study maps the SCLC tumor microenvironment and identifies cancer-associated fibroblasts as key drivers of neuroendocrine state plasticity and poor prognosis.

bioRxiv · Feb 9, 2024Cancer Biology

High neutralizing antibody levels against SARS-CoV-2 Omicron after UB-612 booster vaccination

F. Guirakhoo, S. Wang, C. Y. Wang, H.-K. Kuo, W.-J. Peng, H. Liu, L. Wang, M. Johnson, A. Hunt, M. M. Hu, T. P. Monath, A. Rumyantsev, D. Goldblatt

This study shows that a UB-612 booster vaccine significantly increases neutralizing antibodies against SARS-CoV-2 variants, including Omicron, with estimated 95% efficacy against the ancestral strain.

bioRxiv · Mar 18, 2022Immunology

Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.

M. Johnson, H. Wagstaffe, K. C. Gilmour, A. L. Mai, J. Lewis, A. Hunt, J. Sirr, C. Bengt, L. Grandjean, D. Goldblatt

This study evaluates a multiplexed assay for detecting IgG levels and functional activity against SARS-CoV-2 antigens, finding high sensitivity and specificity for S, RBD, and N antigens.

bioRxiv · Jul 20, 2020Immunology

A three-dimensional musculoskeletal model of the dog

H. Stark, M. S. Fischer, A. Hunt, F. Young, R. Quinn, E. Andrada

The paper develops a 3D musculoskeletal model of dogs with 84 degrees of freedom and 134 muscles to study joint load and locomotion, validated using experimental data on forelimb muscle synergies.

bioRxiv · Jul 16, 2020Bioengineering

Global profiling of myristoylation in Toxoplasma gondii reveals key roles for lipidation in CDPK1 and MIC7 function

M. Broncel, C. Dominicus, A. Hunt, B. A. Wallbank, S. Federico, J. C. Young, M. Treeck

The paper identifies 65 myristoylated proteins in Toxoplasma gondii, highlighting roles for myristoylation in CDPK1 signaling and MIC7 function during host cell invasion.

bioRxiv · Jul 30, 2019 · PreprintMicrobiology

Differential requirements of cyclase associated protein (CAP) for actin turnover during the lytic cycle of Toxoplasma gondii

A. Hunt, J. Wagener, R. Kent, R. Carmeille, M. Russell, C. Peddie, L. Collinson, A. Heaslip, G. E. Ward, M. Treeck

This study investigates the role of cyclase-associated protein (CAP) in actin turnover during the Toxoplasma gondii lytic cycle, finding differential requirements for CAP in cell-cell communication and residual body formation.

bioRxiv · Mar 6, 2019 · PreprintMicrobiology